Abrdn Life Sciences Investors (HQL)
NYSE: HQL · Real-Time Price · USD
17.53
-0.03 (-0.17%)
Apr 28, 2026, 4:00 PM EDT - Market closed
HQL Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Current | FY 2025 | FY 2024 | FY 2022 | FY 2021 | FY 2020 |
| Apr '26 Apr 28, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 |
| Market Capitalization | 533 | 448 | 412 | 343 | 505 | 413 | |
| Market Cap Growth | - | 8.58% | 20.08% | -31.99% | 22.27% | 20.21% | |
| Enterprise Value | 533 | 448 | 412 | 352 | 505 | 413 | |
| Last Close Price | 17.53 | 14.57 | 12.38 | 9.08 | 12.65 | 9.85 | |
| PE Ratio | 6.06 | 5.23 | 4.84 | - | 7.83 | 3.36 | |
| PS Ratio | 275.00 | 231.02 | 103.63 | 113.77 | 220.89 | 121.78 | |
| PB Ratio | 1.01 | 0.87 | 0.90 | 0.86 | 0.97 | 0.85 | |
| P/TBV Ratio | 1.04 | 0.87 | 0.90 | 0.86 | 0.97 | 0.85 | |
| P/OCF Ratio | 16.81 | 14.12 | - | - | - | - | |
| EV/Sales Ratio | 274.96 | 231.02 | 103.63 | 116.55 | 220.89 | 121.78 | |
| Debt / Equity Ratio | - | - | - | 0.03 | 0.02 | 0 | |
| Net Debt / Equity Ratio | 0 | 0 | 0 | 0.03 | 0.02 | 0 | |
| Asset Turnover | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.01 | |
| Quick Ratio | 0.71 | 0.71 | 0.27 | 0.04 | 0.01 | 0.28 | |
| Current Ratio | 0.73 | 0.73 | 0.32 | 0.70 | 0.80 | 8.88 | |
| Return on Equity (ROE) | 17.59% | 17.59% | 19.80% | -22.71% | 12.82% | 28.38% | |
| Return on Assets (ROA) | -0.43% | -0.43% | -0.28% | -0.39% | -0.51% | -0.30% | |
| Return on Capital Employed (ROCE) | -0.70% | -0.70% | -0.40% | -0.80% | -0.80% | -0.40% | |
| Earnings Yield | 16.06% | 19.11% | 20.68% | -30.45% | 12.78% | 29.79% | |
| Dividend Yield | 10.38% | 12.50% | 13.41% | 16.19% | 13.20% | 14.93% | |
| Payout Ratio | 66.05% | 36.96% | - | - | - | - | |
| Buyback Yield / Dilution | -5.48% | -5.48% | -9.28% | -4.10% | -3.29% | -3.03% | |
| Total Shareholder Return | 4.90% | 7.02% | 4.13% | 12.09% | 9.91% | 11.89% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.